Sacubitril-Valsartan in Patients Requiring Hemodialysis
Article in JAMA Network Open (August 2024)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
Real-world experience of angiotensin receptor-neprilysin inhibitors in patients with heart failure and dialysis
Article in Frontiers in Cardiovascular Medicine (July 2024)
Comparison of the Efficacy and Safety of Sacubitril/Valsartan and Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Patients With Reduced Ejection Fraction Combined With Moderate-to-Severe Chronic Kidney Disease.
Article in Journal of Cardiovascular Pharmacology and Therapeutics (July 2024)